dna specimen provenance assay preventing overdiagnosis of prostate cancer
Published 5 years ago • 72 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
11:33
use of mri targeting increases overdiagnosis and overtreatment
-
11:54
screening and prevention of prostate cancer 2021 - who needs a biopsy?
-
14:14
genetic testing and next generation dna sequencing in prostate cancer
-
10:13
the role of genetic testing in prostate cancer
-
10:26
review of sentinel assay for prostate cancer diagnosis
-
23:10
genetic testing and next generation dna sequencing in prostate cancer
-
16:36
early diagnosis of prostate cancer: a path forward
-
7:11
genetics and biomarkers for prostate cancer and bladder cancer
-
14:50
the "who's" of genomic markers: who to re biopsy
-
13:25
progess in understanding pathology of prostate cancer
-
5:57
the engagement study - virtual genetics board for improving prostate cancer genetic testing
-
15:41
dr. concepcion - genetic testing and prostate cancer 1
-
40:22
biomarkers: psa, 4k, or phi?
-
16:25
forward progress in molecular markers in prostate cancer
-
29:23
how should we monitor patients during surveillance?
-
48:12
considerations to improve screening for prostate cancer
-
0:55
when should you do genetic testing? #markscholzmd #prostatecancer
-
0:13
for some people, myself included, a dna test reveals a marker for prostate cancer. #prostatecancer
-
17:40
when to biopsy: the role for psa and novel biomarkers